Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pegylated liposomal doxorubicin (Caelyx)|DRUG: Epirubicin
Sponsor: Hellenic Oncology Research Group
Collaborators: University Hospital of Crete